• For Supporters

Philanthropic support powers progress, enabling our researchers to take risks, challenge, and innovate

Chris Gethin is the Director of Philanthropy at Cancer Research UK. Eight months after launching the largest philanthropic campaign by a UK charity, he shares his thoughts on the evolving landscape of high-value giving. Chris Gethin is the Director of Philanthropy at Cancer Research UK. Eight months after launching the largest philanthropic campaign by a UK charity, he shares his thoughts on the evolving landscape of high-value giving.

10 October 2024

• Personal Stories

A tale of two diagnoses: A patient’s perspective on the importance of earlier diagnosis

Michael, who spoke at our early diagnosis conference this year, tells the story of his two cancer diagnoses and gives his perspective on the importance of early diagnosis Michael, who spoke at our early diagnosis conference this year, tells the story of his two cancer diagnoses and gives his perspective on the importance of early diagnosis

10 October 2024

• For Supporters

Cancer Research UK's philanthropy campaign reaches £200m milestone

Cancer Research UK’s More Research, Less Cancer campaign has raised more than £200m, over halfway towards the £400m target. Cancer Research UK’s More Research, Less Cancer campaign has raised more than £200m, over halfway towards the £400m target.

9 October 2024

• Personal Stories

“It must be more than just bad luck – it must be genetic”: Three women with BRCA gene mutations share their experiences

As we look back on 30 years since the discovery of BRCA1, here three women with faulty BRCA genes share their experiences of cancer.   As we look back on 30 years since the discovery of BRCA1, here three women with faulty BRCA genes share their experiences of cancer.  

9 October 2024

• For Researchers

A vision of the future with C-Further

We chatted to David Jenkinson of LifeArc about C-Further, our new children's cancer therapeutic consortium. We chatted to David Jenkinson of LifeArc about C-Further, our new children's cancer therapeutic consortium.

8 October 2024

• Health & Medicine

Next-gen personalised radiotherapy could cure more bladder cancers and cut side effects

A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies.  A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies. 

7 October 2024

• Policy & Insight

What did party conference season mean for cancer?

Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer. Ian Caleb, public affairs manager, reviews the Liberal Democrat, Labour and Conservative party conferences and explains what they mean for cancer.

4 October 2024

• Charity News

£600,000 given to create the world’s first ovarian cancer prevention vaccine

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

4 October 2024

• Science & Technology
• Health & Medicine

Introducing DIY steps to genetic testing could catch more BRCA-linked cancer cases

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

1 October 2024